261 related articles for article (PubMed ID: 37997816)
21. [Carcinogenesis and Gut Microbiota].
Shiotani A; Fukushima S; Matsumoto H
Gan To Kagaku Ryoho; 2019 Feb; 46(2):199-204. PubMed ID: 30914517
[TBL] [Abstract][Full Text] [Related]
22. The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders.
Islam MR; Arthur S; Haynes J; Butts MR; Nepal N; Sundaram U
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276983
[TBL] [Abstract][Full Text] [Related]
23. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.
Jennison E; Byrne CD
Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiome Changes in Gestational Diabetes.
Ionescu RF; Enache RM; Cretoiu SM; Gaspar BS
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361626
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiome and its role in colorectal cancer.
Rebersek M
BMC Cancer; 2021 Dec; 21(1):1325. PubMed ID: 34895176
[TBL] [Abstract][Full Text] [Related]
26. Gut Microbiota and Alimentary Tract Injury.
Chen Y; Wu G; Zhao Y
Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
[TBL] [Abstract][Full Text] [Related]
27. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
[TBL] [Abstract][Full Text] [Related]
28. [Gut Microbiome and Colorectal Cancer].
Gweon TG
Korean J Gastroenterol; 2023 Aug; 82(2):56-62. PubMed ID: 37621240
[TBL] [Abstract][Full Text] [Related]
29. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
Anto L; Blesso CN
J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
[TBL] [Abstract][Full Text] [Related]
30. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
31. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot.
Aygün C; Tözün N
J Gastrointest Cancer; 2021 Dec; 52(4):1309-1313. PubMed ID: 34750696
[TBL] [Abstract][Full Text] [Related]
33. Remodeling of the Gut Microbiota in Colorectal Cancer and its Association with Obesity.
Zafari N; Velayati M; Mehrabadi S; Damavandi S; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2023; 29(4):256-271. PubMed ID: 36654469
[TBL] [Abstract][Full Text] [Related]
34. The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development.
Genua F; Raghunathan V; Jenab M; Gallagher WM; Hughes DJ
Front Oncol; 2021; 11():626349. PubMed ID: 33937029
[TBL] [Abstract][Full Text] [Related]
35. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
[TBL] [Abstract][Full Text] [Related]
36. Association of the microbiome with colorectal cancer development (Review).
Abdulla MH; Agarwal D; Singh JK; Traiki TB; Pandey MK; Ahmad R; Srivastava SK
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760154
[TBL] [Abstract][Full Text] [Related]
37. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
38. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
Schwabe RF; Greten TF
J Hepatol; 2020 Feb; 72(2):230-238. PubMed ID: 31954488
[TBL] [Abstract][Full Text] [Related]
40. Gut
Precup G; Vodnar DC
Br J Nutr; 2019 Jul; 122(2):131-140. PubMed ID: 30924428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
